Press release
Global Lenvatinib Market Trends, Business Overview, Industry Growth and Forecast to 2022-2028
The lenvatinib market is anticipated to grow at a significant CAGR 5% during the forecast period (2022-2028). Lenvatinib is a medicine used in the treatment of symptoms of differentiated thyroid cancer, advanced renal cell carcinoma, hepatocellular carcinoma, and endometrial cancer. It can be used alone or in combination with other drugs. The major factors driving the growth of the market are the rising prevalence of cellular carcinoma and thyroid cancer. According to the American Society for Clinical Oncology, in 2022, an estimated 44,280 adults (12,150 men and 32,130 women) in the US will be diagnosed with thyroid cancer. Thyroid cancer is the seventh most common cancer in women. Similarly, according to the American Cancer Society, in 2022, around 79,000 new cases of kidney cancer (50,290 in men and 28,710 in women) will be diagnosed and around 13,920 people (8,960 men and 4,960 women) will die from this disease.The global lenvatinib market is segmented based on application and distribution channels. Based on application, the market is sub-segmented into thyroid cancer, renal cell carcinoma, hepatocellular carcinoma, and endometrial cancer. Based on distribution channels, the market is sub-segmented into hospital pharmacies, retail pharmacies, and online pharmacies.
The market players are also contributing significantly to the market growth by adopting various strategies, including mergers, acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market. For instance, in February 2020, Shilpa Medicare Ltd. announced that the company had received regulatory approval to market a lenvatinib mesylate, a breakthrough therapy for the treatment of patients with differentiated thyroid cancer and hepatocellular carcinoma. Shilpa had received regulatory approval for Lenvatinib 4 mg and 10 mg capsules, after successfully showing bioequivalence to Lenvima, a brand of Lenvatinib mesylate capsules marketed by Eisai.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Global Lenvatinib Market at:
https://orionmarketreports.com/request-sample/?id=100685&submit=Request+Sample%0D%0A
Market Coverage
• The market number available for - 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Application
o By Distribution Channel
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Merck & Co. Inc., Eisai Pharmaceuticals Co., Bayer AG, Teva Pharmaceutical Industries Ltd., Piramal Enterprises Ltd., Mankind Pharma Ltd., Lupin Ltd., and Pfizer Inc., among others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
A full report of Global Lenvatinib Market is available at:
https://orionmarketreports.com/global-lenvatinib-market/100685/
Global Lenvatinib Market Report by Segment
By Application
• Thyroid Cancer
• Renal Cell Carcinoma
• Hepatocellular Carcinoma
• Endometrial Cancer
By Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others
Global Lenvatinib Market Report by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
Company name: Orion Market Reports
Contact person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
About us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Lenvatinib Market Trends, Business Overview, Industry Growth and Forecast to 2022-2028 here
News-ID: 2607133 • Views: …
More Releases from Orion Market Reports
Module Power Supply Market to see Huge Growth by 2031
The Module Power Supply Market is experiencing substantial growth, fueled by increasing demand for efficient, compact, and reliable power solutions across a wide range of industries. These power supplies, which convert electrical power to a suitable form for specific applications, are essential in sectors like telecommunications, automotive, medical devices, and consumer electronics. With technological advancements and rising energy efficiency needs, the market is expected to continue expanding, driven by innovations…
Plasma Spray Guns Market to see Rapid Growth by 2031
The Plasma Spray Guns Market is witnessing significant growth, driven by the rising demand for surface coating and thermal spray applications across industries such as aerospace, automotive, manufacturing, and electronics. Plasma spray guns are widely used for depositing coatings on substrates to enhance their properties, including wear resistance, corrosion resistance, and thermal protection. As industries continue to focus on improving product performance and durability, the plasma spray gun market is…
Plasma Surface Treatment Machine Market Will Generate Record Revenue by 2031
The Plasma Surface Treatment Machine Market is witnessing significant growth as industries increasingly adopt plasma surface treatment technology for enhancing the properties of materials. Plasma surface treatment machines are used to modify the surface characteristics of materials like metals, plastics, and ceramics, offering improvements in adhesion, corrosion resistance, and wear resistance. As the demand for advanced surface treatments rises across automotive, electronics, packaging, and manufacturing sectors, the market for plasma…
Plasma Torch Market Value Projected to Expand by 2031
The Plasma Torch Market is experiencing rapid growth, driven by the increasing demand for high-precision cutting and welding technologies in industries such as manufacturing, automotive, aerospace, and construction. Plasma torches are essential tools in thermal cutting applications, offering fast and accurate cuts on various materials, including metals, plastics, and composites. With advancements in plasma cutting technology and the growing need for energy-efficient solutions, the market for plasma torches continues to…
More Releases for Lenvatinib
Lenvatinib Global Market Report 2024: Pricing, Distribution, and Promotion - Str …
Lenvatinib (trade name Lenvima) is an anti-cancer drug for the treatment of certain kinds of thyroid cancer and for other cancers as well. It was developed by Eisai Co. and acts as a multiple kinase inhibitor against the VEGFR1, VEGFR2 and VEGFR3 kinases.
QY Research (Market Research Report Publisher) announces the release of its lastest report "Lenvatinib - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030". Based…
Lenvatinib + Pembrolizumab Poised for Remarkable Market Expansion of Metastatic …
[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on Lenvatinib + Pembrolizumab (Eisai and Merck) providing insights into the drug market landscape and market forecast of Lenvatinib + Pembrolizumab upto 2032. The report, titled "Lenvatinib + pembrolizumab Market Size, Forecast, and Emerging Insight - 2032" is now available for review and analysis.
Are you interested in finding out the projected market…
Lenvatinib Mesilate Capsules Market Analysis And Upcoming Trend By 2028|Shilpa M …
QY Research has recently published a new report, titled Global Lenvatinib Mesilate Capsules Market Report, History and Forecast 2017-2028, Breakdown Data by Manufacturers, Key Regions, Types and Application. The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Lenvatinib Mesilate Capsules market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment…
Lenvatinib Market May See a Big Move by 2028
Most important aspects are gathered in this Lenvatinib market study report including visions, technical advances, market constraints, present market trends, and market growth factors and market drivers. All of these vital aspects greatly help to boost the business growth. Attentive estimation of marketplace is performed here to allow key firms get updated and latest view of current market scenario and even forthcoming potential projection. A few of the significant aspects…
Lenvatinib Mesilate Capsules Market Segments, Opportunity, Growth and Forecast b …
LOS ANGELES, United States: QY Research offers an encyclopedic study of the global Lenvatinib Mesilate Capsules market with holistic insights into vital factors and aspects that impact future market growth. The global Lenvatinib Mesilate Capsules market has been analyzed for the forecast period 2022-2028 and historical period 2017-2021. In order to help players to gain comprehensive understanding of the global Lenvatinib Mesilate Capsules market and its critical dynamics, the research study…
Lenvatinib Market Seeking Excellent Growth by 2020-2025 Report Analysis with Top …
Lenvatinib Market 2020 Global Industry research report studies latest Lenvatinib industry aspects market size, share, trends, growth, business overview and Lenvatinib industry scenario during the forecast period (2020-2025).
Global Lenvatinib Market overview:
Lenvatinib is the generic for the trade name drug Lenvima. In some cases, health care professionals may use the trade name Lenvima when referring to the generic drug name lenvatinib. Drug type: Lenvatinib is a targeted therapy. This medication is…
